Internal Medicine, Pulmonary Disease · Garden City, NY
NPI
1730134339
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
623 Stewart Ave
Garden City, NY, 11530
Phone (516) 741-0055
Groups this clinician bills Medicare through
Medicare paid, 2024
$305K
11,570 services
Medicare patients, 2024
256
Average age 73
Drug cost, 2024
$2.5M
5,274 prescriptions
Company payments, 2025
$6,499
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gurmit S Gill was code 95165 (treatment - miscellaneous), 4,684 times for 73 patients. In total Gurmit S Gill billed 11,570 services in 34 codes, and Medicare paid $305K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 4,684 | 73 | $14.23 | $67K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,769 | 110 | $0.09 | $158 |
| 95004 Test - Miscellaneous | Office | 1,152 | 16 | $3.73 | $4,301 |
| 99214 Office E&M - Established | Office | 656 | 192 | $115.58 | $76K |
| 94060 Pulmonary Function Testing | Office | 614 | 190 | $37.08 | $23K |
| 95117 Treatment - Miscellaneous | Office | 557 | 80 | $12.19 | $6,790 |
| 96372 Injection Administration | Office | 531 | 115 | $13.47 | $7,154 |
| 99213 Office E&M - Established | Office | 299 | 116 | $81.69 | $24K |
| 96401 Chemotherapy Administration | Office | 177 | 33 | $69.80 | $12K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 162 | 47 | $0.98 | $158 |
| 93040 Electrocardiogram | Office | 149 | 103 | $12.53 | $1,867 |
| 99215 Office E&M - Established | Office | 120 | 72 | $160.55 | $19K |
| 99291 Critical Care E&M | Facility | 96 | 25 | $194.29 | $19K |
| 94618 Pulmonary Function Testing | Office | 61 | 61 | $31.43 | $1,917 |
| 94729 Pulmonary Function Testing | Office | 60 | 59 | $52.10 | $3,126 |
By year: 2022 $661K for 18,561 services; 2023 $578K for 19,833 services; 2024 $305K for 11,570 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gurmit S Gill prescribed most often to Medicare patients was Fluticasone Propionate, with 605 prescriptions and refills. In total Gurmit S Gill wrote 5,274 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 605 | 686 | 194 | $6,760 |
| Montelukast Sodium Generic | 584 | 853 | 138 | $4,083 |
| Prednisone Generic | 341 | 368 | 132 | $1,091 |
| Dupixent Syringe Dupilumab | 270 | 275 | 37 | $1.0M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 258 | 285 | 77 | $7,608 |
| Famotidine Generic | 219 | 244 | 61 | $662 |
| Omeprazole Generic | 180 | 225 | 46 | $971 |
| Azithromycin Generic | 157 | 157 | 83 | $593 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 152 | 168 | 32 | $104K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 145 | 145 | 85 | $1,052 |
| Azelastine Hcl Generic | 143 | 200 | 46 | $2,370 |
| Levofloxacin Generic | 126 | 126 | 76 | $508 |
| Zafirlukast Generic | 116 | 127 | 31 | $6,091 |
| Zolpidem Tartrate Generic | 92 | 92 | 16 | $234 |
| Roflumilast Generic | 86 | 98 | 20 | $8,260 |
Brand drugs: 1,106 claims; generic drugs: 4,168 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gurmit S Gill $6,499 ($6,499 in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,372.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 38 | $1,372 |
| Harmony Biosciences LLC HRMY | 38 | $824 |
| GlaxoSmithKline, LLC. GSK | 23 | $681 |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $445 |
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $303 |
| Genzyme Corporation SNY | 7 | $281 |
| Electromed, Inc. ELMD | 8 | $246 |
| Insmed, Inc. INSM | 9 | $229 |
| Amgen Inc. AMGN | 11 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $223 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.